-

Shareholder Alert: Robbins LLP Announces FirstEnergy Corp. (FE) Accused of Misleading Shareholders

SAN DIEGO & AKRON, Ohio--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of FirstEnergy Corp. (NYSE: FE) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between February 21, 2017 and July 21, 2020. FirstEnergy generates, transmits, and distributes electricity in the United States.

If you suffered a loss as a result of FirstEnergy's misconduct, click here.

FirstEnergy Corp. (FE) Accused of Engaging in an Illicit Bribery Scheme

According to the complaint, at the end of fiscal 2016, FirstEnergy reported a weak energy market, poor forecast demand, and hundreds of millions of dollars in losses. To alleviate investor concern, FirstEnergy stated in its annual report for 2016 that it intended to pursue "legislative or regulatory solutions" to remedy its dismal financial prospects. However, FirstEnergy failed to disclose that these solutions included an illicit campaign that funneled tens of millions of dollars to state lawmakers, including Ohio House Speaker Larry Householder, issuing misleading messages on media platforms, and illegally thwarting a citizen's ballot initiative to secure the votes for passage of Ohio House Bill 6 ("HB6"), which provided a $1.3 billion ratepayer-funded bailout to keep FirstEnergy's nuclear facilities in operation. On July 21, 2020, federal agents announced the arrest of Householder and four other individuals, including a prominent FirstEnergy lobbyist in connection with a $60 million racketeering and bribery scheme. The criminal complaint described FirstEnergy's extensive bribery scheme and corruptive tactics to ensure the passage of HB6 as "the largest bribery, money-laundering scheme" in Ohio history. On this news, the price of FirstEnergy stock plummeted, trading as low as $22.85 per share on July 22, 2020, representing a 45% decline from its closing price of $41.26 per share on July 20, 2020.

FirstEnergy Corp. (FE) Shareholders Have Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against FirstEnergy settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors of the Flotek Industries, Inc. (FTK) Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Flotek Industries, Inc. (NYSE: FTK) securities between August 3, 2026 and August 17, 2026 (the "Class Period"). Flotek is an energy technology and services company.The complaint alleges that Flotek misled investors by failing to disclose the cancellation of its $400m Puerto Rican deal.Investors who suffered s...

Robbins LLP Encourages WSE Stockholders with Large Losses to Seek Counsel for the Securities Class Action Lawsuit Against Wise Group plc

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Wise Group plc (NASDAQ: WSE) securities between May 11, 2026 and July 23, 2026 (the "Class Period").The complaint alleges that Wise and certain of its senior executives violated the federal securities laws by making materially false and/or misleading statements regarding the Company's anti-money laundering compliance, a...

Robbins LLP Urges Investors of ARS Pharmaceuticals Inc. to Contact the Firm for Information About the SPRY Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds shareholders that a securities class action has been filed on behalf of all investors who purchased or otherwise acquired ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026 (the "Class Period"). ARS is a clinical stage biopharmaceutical company focused on the development and commercialization of neffy for needle-free intranasal delivery of epinephrine for emergency treatment of Type 1 allergic reactions, incl...
Back to Newsroom